Tempest Therapeutics, Inc. (TPST) Capital expenditures 2016–2025
Tempest Therapeutics, Inc. (TPST) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2025 · since FY2016: $2.6M → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | -100.0% |
| FY2024 | $435,000 | +155.9% |
| FY2023 | $170,000 | -69.8% |
| FY2022 | $562,000 | +316.3% |
| FY2021 | $135,000 | +170.0% |
| FY2020 | $50,000 | -87.4% |
| FY2019 | $397,000 | +1002.8% |
| FY2018 | $36,000 | +800.0% |
| FY2017 | $4,000 | -99.8% |
| FY2016 | $2.6M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice